37 related articles for article (PubMed ID: 23817390)
1. Ceragenin CSA-13 induces cell cycle arrest and antiproliferative effects in wild-type and p53 null mutant HCT116 colon cancer cells.
Kuroda K; Fukuda T; Okumura K; Yoneyama H; Isogai H; Savage PB; Isogai E
Anticancer Drugs; 2013 Sep; 24(8):826-34. PubMed ID: 23817390
[TBL] [Abstract][Full Text] [Related]
2. 3
Tu J; Meng X; Wang J; Han Z; Yu Z; Sun H
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834468
[TBL] [Abstract][Full Text] [Related]
3. Macromolecules with predominant β-pleated sheet proteins in extracellular vesicles released from Raphanus sativus L. var. caudatus Alef microgreens induce DNA damage-mediated apoptosis in HCT116 colon cancer cells.
Kaimuangpak K; Rosalina R; Thumanu K; Weerapreeyakul N
Int J Biol Macromol; 2024 Jun; 269(Pt 1):132001. PubMed ID: 38702007
[TBL] [Abstract][Full Text] [Related]
4. Influence of Fatty Acid Modification on the Anticancer Activity of the Antimicrobial Peptide Figainin 1.
Han Z; Feng D; Wang W; Wang Y; Cheng M; Yang H; Liu Y
ACS Omega; 2023 Nov; 8(44):41876-41884. PubMed ID: 37970064
[TBL] [Abstract][Full Text] [Related]
5. Application Value of Antimicrobial Peptides in Gastrointestinal Tumors.
Liu Q; Wang L; He D; Wu Y; Liu X; Yang Y; Chen Z; Dong Z; Luo Y; Song Y
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069041
[TBL] [Abstract][Full Text] [Related]
6. Nisin ZP, an Antimicrobial Peptide, Induces Cell Death and Inhibits Non-Small Cell Lung Cancer (NSCLC) Progression in vitro in 2D and 3D Cell Culture.
Patil SM; Kunda NK
Pharm Res; 2022 Nov; 39(11):2859-2870. PubMed ID: 35246758
[TBL] [Abstract][Full Text] [Related]
7. From Marine Metabolites to the Drugs of the Future: Squalamine, Trodusquemine, Their Steroid and Triterpene Analogues.
Kazakova O; Giniyatullina G; Babkov D; Wimmer Z
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162998
[TBL] [Abstract][Full Text] [Related]
8. Peanut-Shaped Gold Nanoparticles with Shells of Ceragenin CSA-131 Display the Ability to Inhibit Ovarian Cancer Growth In Vitro and in a Tumor Xenograft Model.
Piktel E; Oscilowska I; Suprewicz Ł; Depciuch J; Marcińczyk N; Chabielska E; Wolak P; Głuszek K; Klimek J; Zieliński PM; Marzec MT; Savage PB; Parlińska-Wojtan M; Bucki R
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771587
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Characterization of Bone Binding Antibiotic-1 (BBA-1), a Novel Antimicrobial for Orthopedic Applications.
Kamble S; Valtchev P; Dao A; Pelras T; Rogers MJ; Savage PB; Dehghani F; Schindeler A
Molecules; 2021 Mar; 26(6):. PubMed ID: 33799713
[TBL] [Abstract][Full Text] [Related]
10. Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells.
Piktel E; Markiewicz KH; Wilczewska AZ; Daniluk T; Chmielewska S; Niemirowicz-Laskowska K; Mystkowska J; Paprocka P; Savage PB; Bucki R
Int J Nanomedicine; 2020; 15():4573-4589. PubMed ID: 32606693
[TBL] [Abstract][Full Text] [Related]
11. Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications.
Wnorowska U; Fiedoruk K; Piktel E; Prasad SV; Sulik M; Janion M; Daniluk T; Savage PB; Bucki R
J Nanobiotechnology; 2020 Jan; 18(1):3. PubMed ID: 31898542
[TBL] [Abstract][Full Text] [Related]
12. Cathelicidin Suppresses Colon Cancer Metastasis via a P2RX7-Dependent Mechanism.
Wang J; Cheng M; Law IKM; Ortiz C; Sun M; Koon HW
Mol Ther Oncolytics; 2019 Mar; 12():195-203. PubMed ID: 30847383
[TBL] [Abstract][Full Text] [Related]
13. Ceragenin CSA-13 as free molecules and attached to magnetic nanoparticle surfaces induce caspase-dependent apoptosis in human breast cancer cells via disruption of cell oxidative balance.
Piktel E; Prokop I; Wnorowska U; Król G; Cieśluk M; Niemirowicz K; Savage PB; Bucki R
Oncotarget; 2018 Apr; 9(31):21904-21920. PubMed ID: 29774111
[TBL] [Abstract][Full Text] [Related]
14. Sporicidal activity of ceragenin CSA-13 against Bacillus subtilis.
Piktel E; Pogoda K; Roman M; Niemirowicz K; Tokajuk G; Wróblewska M; Szynaka B; Kwiatek WM; Savage PB; Bucki R
Sci Rep; 2017 Mar; 7():44452. PubMed ID: 28294162
[TBL] [Abstract][Full Text] [Related]
15. Core-shell magnetic nanoparticles display synergistic antibacterial effects against
Niemirowicz K; Piktel E; Wilczewska AZ; Markiewicz KH; Durnaś B; Wątek M; Puszkarz I; Wróblewska M; Niklińska W; Savage PB; Bucki R
Int J Nanomedicine; 2016; 11():5443-5455. PubMed ID: 27799768
[TBL] [Abstract][Full Text] [Related]
16. Recombinant expression and biological characterization of the antimicrobial peptide fowlicidin-2 in
Xing LW; Tian SX; Gao W; Yang N; Qu P; Liu D; Jiao J; Wang J; Feng XJ
Exp Ther Med; 2016 Oct; 12(4):2324-2330. PubMed ID: 27698732
[TBL] [Abstract][Full Text] [Related]
17. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
[TBL] [Abstract][Full Text] [Related]
18. The Role of Cathelicidin LL-37 in Cancer Development.
Piktel E; Niemirowicz K; Wnorowska U; Wątek M; Wollny T; Głuszek K; Góźdź S; Levental I; Bucki R
Arch Immunol Ther Exp (Warsz); 2016 Feb; 64(1):33-46. PubMed ID: 26395996
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal Activity of Ceragenin CSA-13 in Cell Culture and in an Animal Model of Peritoneal Infection.
Bucki R; Niemirowicz K; Wnorowska U; Byfield FJ; Piktel E; Wątek M; Janmey PA; Savage PB
Antimicrob Agents Chemother; 2015 Oct; 59(10):6274-82. PubMed ID: 26248361
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
